Niki Karagianni, Ph.D
Chief Scientific Officer
Dr. Niki Karagianni obtained her Bachelor’s degree in Chemistry from the Athens University and completed her Ph.D. in the Biology Department of the same University on the role of glucocorticoid receptors in the transcriptional regulation of early response genes. She joined as postdoctoral fellow the Tumour Immunology Programme, at DKFZ, Heidelberg, Germany, where she worked on the generation of transgenic and knockout mice as well as gene transfer approaches targeting undifferentiated cells, Prof. D. Paulin’s lab in University of Paris VII and Prof. H.von Boehmer’s lab in the Faculty of Medicine, Necker Enfants-Malades working with in vivo gene delivery using retroviral and adenoviral vectors as well as the generation of conditional knockout and transgenic mice. In 2003 Dr. Karagianni joined the Laboratory of Dr. G. Kollias at BSRC Fleming, Vari-Athens, Greece, to work on the generation and characterization of “humanized” knockin, knockout and transgenic models, as well as on the development of anti-TNFR1 therapeutic approaches.
In September 2009, Dr. Karagianni joined Biomedcode’s Scientific Management Team as the Head of R&D department.